For patients living with inflammatory bowel disease (IBD), maintaining consistent biologic therapy is one of the most important factors in achieving long-term remission. Clinical evidence has shown that adherence to scheduled biologic treatments significantly reduces disease flare-ups, promotes mucosal healing, and lowers the risk of hospitalization and surgery. Interruptions in therapy, however, may lead to […]
